載入...
Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?
Metformin is the most commonly used glucose-lowering therapy (GLT) worldwide and remains the first-line therapy for newly diagnosed individuals with type 2 diabetes (T2D) in management algorithms and guidelines after the UK Prospective Diabetes Study (UKPDS) showed cardiovascular mortality benefits...
Na minha lista:
| 發表在: | Pharmaceuticals (Basel) |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7761522/ https://ncbi.nlm.nih.gov/pubmed/33261058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13120427 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|